# Exploratory Study on POL6326 in Stem Cell Mobilization

> **NCT01105403** · PHASE2 · COMPLETED · sponsor: **Polyphor Ltd.** · enrollment: 21 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** POL6326

## Key facts

- **NCT ID:** NCT01105403
- **Lead sponsor:** Polyphor Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2014-02
- **Final completion:** 2014-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2014-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105403, "Exploratory Study on POL6326 in Stem Cell Mobilization". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01105403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*